1 2 A fundamental question in the biology of sex-differences has eluded 3 direct study in humans: how does sex chromosome dosage (SCD) shape 4 genome function? To address this, we developed a systematic map of SCD 5 effects on gene function by analyzing genome-wide expression data in 6 humans with diverse sex chromosome aneuploidies (XO, XXX, XXY, XYY, 7 XXYY). For sex chromosomes, we demonstrate a pattern of obligate 8 dosage sensitivity amongst evolutionarily preserved X-Y homologs, and 9 revise prevailing theoretical models for SCD compensation by detecting X-10 linked genes whose expression increases with decreasing X-and/or Y-11 chromosome dosage. We further show that SCD-sensitive sex 12 chromosome genes regulate specific co-expression networks of SCD-13 sensitive autosomal genes with critical cellular functions and a 14 demonstrable potential to mediate previously documented SCD effects on 15 disease. Our findings detail wide-ranging effects of SCD on genome 16 function with implications for human phenotypic variation. 17 18 19 20 21 22 23 wide consequences of SCD through comparative transcriptomic analyses 47 amongst humans across a range of dosages including typical XX and XY 48
INTRODUCTION 24
Disparity in SCD is fundamental to the biological definition of sex 25 throughout much of the animal kingdom. In almost all eutherian mammals, 26 females carry two X-chromosomes, while males carry an X-and a Y-27 chromosome: presence of the Y-linked SRY gene determines a testicular 28 gonadal phenotype, while its absence allows development of ovaries 1 . Sexual 29 differentiation of the gonads leads to hormonal sex-differences that have 30 traditionally been considered the major proximal cause for extra-gonadal 31 phenotypic sex-differences. However, diverse studies, including recent work in 32 transgenic mice that uncouple Y-chromosome and gonadal status, have revealed 33 direct SCD effects on several sex-biased metabolic, immune and neurological 34 phenotypes 2 . 35
These findings -together with reports of widespread transcriptomic 36 differences between pre-implantation XY and XX embryos 3, 4 -suggest that SCD 37 has gene regulatory effects independently of gonadal status. However, genome-38 wide consequences of SCD remain poorly understood, especially in humans, 39
where experimental dissociation of SCD and gonadal status is not possible. 40
Understanding these regulatory effects is critical for clarifying the biological 41 underpinnings of phenotypic sex-differences, and the clinical features of sex 42 chromosome aneuploidy 5 [SCA, e.g. Turner (XO) and Klinefelter (XXY) 43 syndrome], which can both manifest as altered risk for several common 44 autoimmune and neurodevelopmental disorders (e.g. systemic lupus 45 erythematosus and autism spectrum disorders) 6, 7 . Here, we explore the genome 46 5 persistent pattern of significant differential expression (DE) across all unique 70 pairwise group contrasts involving a disparity in either X-or Y-chromosome 71 dosage (n=15 and n=16 contrasts respectively, Fig. 1a ). Disparities in X-72 chromosome dosage were always accompanied by statistically significant DE in 73 4 genes, which were all X-linked: XIST (the orchestrator of X-inactivation) and 3 74 other known genes known to escape X-chromosome inactivation (PUDP, 75 KDM6A, EIF1AX) 8 . Similarly, disparities in Y-chromosome dosage always led to 76 statistically-significant DE in 6 genes, which were all Y-linked: CYorf15B, DDX3Y, 77 TMSB4Y, USP9Y, UTY, and ZFY. Observed expression profiles for these 10 78 genes perfectly segregated all microarray samples by karyotype group (Fig. 1b) , 79
and could be robustly replicated and extended in the independent sample of 80
LCLs from 401 participants with varying SCD (Supplementary Fig. 1, Methods) . 81
Strikingly, 8 of the 10 genes showing obligatory SCD sensitivity (excepting 82 XIST and PUPD) are members of a class of 16 sex-linked genes with homologs 83 on both the X and Y chromosomes (i.e. 16 X-Y gene pairs, henceforth 84 gametologs) 9 that are distinguished from other sex-linked genes by (i) their 85 selective preservation in multiple species across ~300 million years of sex 86 chromosome evolution to prevent male-female dosage disparity, (ii) the breadth 87 of their tissue expression from both sex chromosomes; and (iii) their key 88 regulatory roles in transcription and translation 9, 10 (Fig. 1c) . Broadening our 89 analysis to all 14 X-Y gametolog pairs present in our microarray data found that 90 these genes as a group exhibit a heightened degree of SCD-sensitivity that 91 distinguishes them from other sex-linked genes (Fig. 1d, Methods) . These 92 6 findings provide the strongest evidence to date that the evolutionary 93 maintenance, broad tissue expressivity and enriched regulatory functions of X-Y 94 gametologs 10 are indeed accompanied by a distinctive pattern of dosage 95 sensitivity, which firmly establishes these genes as candidate regulators of SCD 96 effects on wider genome function. Table providing Gene ID, location, 105 function and homolog annotations for the 10 genes that showed obligate SCD sensitivity. Eight 106 genes in this set are members of X-Y gametolog gene pairs. d) Density plots showing observed 107 mean SCD sensitivity of the 14 gametolog genes in our study (red line), vs, distribution (black 108 line) of 10,000 randomly sampled sets of non-gametolog sex-linked genes of equal size. Results
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Purple "cluster" (Fig. 2b) . For all but the Orange cluster of PAR genes, observed 143 patterns of gene-cluster dosage sensitivity across karyotype groups deviated 144 from those predicted by the Four Class Model in several substantial ways ( Fig.  145   2c) . 146
Mean Expression for the Pink cluster of Y-linked genes increased in a 147 stepwise fashion with Y-chromosome dosage, but countered the Four Class 148
Model prediction by showing a sub-linear relationship with Y-chromosome count 149 -indicting that these Y-linked genes may be subject to active dosage 150 compensation. Fold-changes observed by microarray for 5/5 of these Y-linked 151 genes were highly replicable by qPCR in an independent sample of 401 152 participants with varying SCD (Methods, Supplementary Fig. 2c ). 153
Four Class Model predictions were also challenged by observed 154 expression profiles for the Yellow and Green clusters of X-linked genes ( Table 2 , 155 Fig. 2c,d) . Linear models for X and Y chromosome dosage effects on expression 156 (Methods) indicated that the XCI-enriched Yellow cluster was highly sensitive to 157 SCD (F=47.7, p<2.2*10 -16 ), and expression of genes in this cluster was 158 significantly inversely related to X-chromosome dosage at the level of both mean 159 cluster expression (coefficient for linear effect of X-chromosome count on 160 expression = -0.12, p=3.8*10 -15 ) and the individual expression profile of 60/66 161 genes within the cluster (p<0.05 for negative linear effect of X count on 162 expression). This observation indicates that increasing X copy number does not 163 solely involve silencing of these genes from the inactive X-chromosome, but a 164 further repression of their expression from the additional active X-chromosome. 165
Remarkably, mean expression of the XCI gene cluster was also 166 significantly decreased by presence of a Y-chromosome at the level of both 167 mean cluster expression (coefficient for linear effect of Y-chromosome count on 168 expression = -0.09, p= 1.4*10 -14 ) and expression profiles of 48/66 individual 169 cluster genes (p<0.05 for negative linear effect of Y count on expression). The 170
Green XCIE cluster manifested an inverted version of this effect whereby 171 increases in Y chromosome dosage were associated with increased gene 172 expression (p< 6.2* 10-11 for mean cluster expression and p<0.05 for 23/39 cluster 173 genes) -providing the first evidence that Y-chromosome status can influence the 174 expression level of X-linked genes independently of circulating gonadal factors. 175
Finally, mean fold change for XCIE-cluster genes scaled sub-linearly with X-176 chromosome dosage. Importantly, mean expression profiles for XCIE-and XCI-177 enriched gene clusters still deviated from predictions of the Four Class Model 178 when analysis was restricted to genes with the highest-confidence (i.e. 179 independently replicated across 3 independent studies 8 ) XCIE and XCI status 180 (respectively) in each cluster ( Fig. 2d) . 181
To determine the reproducibility and validity of these unexpected modes of 182 dosage sensitivity in XCI and XCIE gene, we first confirmed that the distinct 183 expression profiles for these two clusters across karyotype groups were 184 reproducible at the level of individual genes and samples. Indeed, unsupervised 185 clustering of microarray samples based on expression of XCI and XCIE cluster 186 genes relative to XX controls distinguished three broad karyotype groups: 187 females with one X-chromosome (XO), males with one X-chromosome (XY, 188 XYY), and individuals with extra X-chromosome (XXX, XXY, XXYY) ( Fig. 2e) . 189
We were also able to validate our data-driven discovery of XCI and XCIE gene 190 clusters against independently generated X-chromosome annotations ( Fig. 2f) , 191 which detail 3 distinct genomic predictors of inactivation status for X-linked 
219
Observed mean expression profiles counter still counter predictions when analysis is restricted to 220 core genes in each cluster with XCIE/XCI status that has been confirmed across three 
Context-Specific Disruption of Autosomal Expression by Sex Chromosome 234
Aneuploidy 235
We next leveraged the diverse SCAs represented in our study to assess 236 how SCD variation shapes expression on a genome-wide scale. By counting the 237 total number of differentially expressed genes (DEGs, Methods) in each SCA 238 group relative to its respective euploidic control (i.e XO and XXX compared with 239 XX; XXY, XYY, XXYY compared with XY), we detected order of magnitude 240 differences in DEG count amongst SCAs across a range of log2 fold change 241 (log2FC) cut-offs ( Fig. 3a,b) . We observed an order of magnitude increase in 242 DEG count with X-chromosome supernumeracy in males vs. females, which 243 although previously un-described, is congruent with the more severe phenotypic 244 consequences of X-supernumeracy in males vs. females 15 . Overall, increasing 245 the dosage of the sex chromosome associated with the sex of an individual (i.e. 246 X in females and Y in males) had a far smaller effect than other types of SCD 247 changes. Moreover, the ~20 DEGs seen in XXX contrasted with >2000 DEGs in 248 XO -revealing a profoundly asymmetric impact of X-chromosome loss vs. gain 249 on the transcriptome of female LCLs, which echoes the asymmetric phenotypic 250 severity of X-chromosome loss (Turner) vs. gain (XXX) syndromes in females 6 . 251
To clarify the relative contribution of sex chromosome vs. autosomal 252 genes to observed DEG counts with changes in SCD, we calculated the 253 proportion of DEGs in every SCD group (comparing SCAs to their "gonadal 254 controls", and XY males to XX females) that fell within each of four distinct 255 genomic regions: autosomal, PAR, Y-linked and X-linked ( Fig. 3c) . Autosomal 256 genes accounted for >75% of all DEGs in females with X-monosomy (XO) and 257 males with X-supernumeracy (XXY, XXYY), but <30% DEGs in all other SCD 258 groups (Methods). These results reveal that SCD changes vary widely in their 259 capacity to disrupt genome function, and demonstrate that differential 260 involvement of autosomal genes is central to this variation. Moreover, associated 261 SCA differences in overall DEG count broadly recapitulate SCA differences in 262 phenotypic severity. 
Sex Chromosome Dosage Regulates Large-Scale Gene Co-expression 292
Networks 293
To provide a more comprehensive systems-level perspective on the 294 impact of SCD on genome-wide expression patterns, we leveraged Weighted 295
Gene Co-expression Network Analysis 16 (WGCNA, Methods). This analytic 296 approach uses the correlational architecture of gene expression across a set of 297 samples to detect sets (modules) of co-expressed genes. Using WGCNA, we 298 identified 18 independent gene co-expression modules in our dataset ( Table 3) . 299
We established that these modules were not artifacts of co-differential expression 300 of genes between groups by demonstrating their robustness to removal of all 301 group effects on gene expression by regression ( Supplementary Fig. 3a) , and 302 after specific exclusion of XO samples ( Supplementary Fig. 3b ) given the 303 extreme pattern of DE in this karyotype (Fig. 3b) . We focused further analysis on 304 modules meeting 2 independent statistical criteria after correction for multiple 305 comparisons: (i) significant omnibus effect of SCD group on expression, (ii) 306 significant enrichment for one or more gene ontology (GO) process/function 307 terms (Methods, Table 3 , Fig. 4a-b) . These steps defined 8 functionally 308 coherent and SCD-sensitive modules (Blue, Brown, Green, Purple, Red, Salmon, 309
Tan and Turquoise). Notably, the SCD effects we observed on genome wide 310 expression patterns appeared to be specific to shifts in sex chromosome gene 311 dosage, as application of our analytic workflow to publically available genome-312 wide Illumina beadarray expression data from LCLs in patients with trisomy 21 313 (Down syndrome) revealed a highly dissimilar profile of genome-wide expression 314 change to that observed in sex chromosome trisomies (Methods, Fig. 3c , Table  315 4). 316
To specify SCA effects on module expression, we compared all 317 aneuploidy groups to their respective "gonadal controls" (Fig. 3d) . Statistically 318 significant differences in modular eigengene expression were seen in XO, XXY 319 and XXYY groups -consistent with these karyotypes causing larger total DE 320 gene counts than other SCD variations (Fig. 3a) . To test for evidence of coordination between the changes in sex-350 chromosome genes imparted by SCD (Fig. 2) , and the genome-wide 351 transcriptomic variations detected through WGCNA (Fig. 4a) , we asked if any 352 SCD-sensitive gene co-expression modules were enriched for one or more of the 353 5 SCD-sensitive clusters of sex chromosome genes (i.e. "PAR", "Y-linked", 354 "XCIE", "XCI" and the gene XIST). Four WGCNA modules -all composed of 355 >95% autosomal genes -showed such enrichment (Fig. 4e) : The Turquoise and 356
Brown modules were enriched for XCI cluster genes, whereas the Green and 357
Blue modules were enriched for XCIE cluster genes. The Blue module was 358 unique for its additional enrichment in PAR genes, and its inclusion of XIST. We 359 generated network visualizations to more closely examine SCD-sensitive genes 360 20 and gene co-expression relationships within each of these four sex-chromosome 361 enriched WGCNA modules (Fig 3f Blue and Supplementary Figure 3c -e for 362 others, Methods). The Blue module network highlights XIST, select PAR genes 363 (SLC25A6, SFRS17A) and multiple X-linked genes from X-Y gametolog pairs 364 (EIF1AX, KDM6A (UTX), ZFX, PRKX) for their high SCD-sensitivity, and shows 365 that these genes are closely co-expressed with multiple SCD-sensitive 366 autosomal genes including ZWINT, TERF2IP and CDKN2AIP. 367
Our detection of highly-organized co-expression relationships between 368 SCD sensitive sex-linked and autosomal genes hints at specific regulatory effects 369 of dosage sensitive sex chromosome genes in mediating the genome-wide 370 effects of SCD variation. To test this, and elucidate potential regulatory 371 mechanisms, we performed an unbiased transcription factor binding site (TFBS) 372 enrichment analysis of genes within Blue, Green, Turquoise and Brown WGCNA 373 modules (Methods). This analysis converged on a single TF -ZFX, encoded by 374 the X-linked member of an X-Y gametolog pair -as the only SCD sensitive TF 375 showing significant TFBS enrichment in one or more modules. Remarkably, the 376 gene ZFX was itself part of the Blue module, and ZFX binding sites were not only 377 enriched amongst Blue and Green module genes (increased in expression with 378 increasing X-chromosome dose), but also amongst Brown module genes that are 379 downregulated as X-chromosome dose increases (Fig. 4g) . To directly test if 380 changes in ZFX expression are sufficient to modify expression of Blue, Green or 381
Brown modules genes in immortalized lymphocytes, we harnessed existing 382
gene-expression data from murine T-lymphoblastic leukemia cells with and 383
without ZFX knockout 17 (GEO GSE43020). These data revealed that genes 384 downregulated by ZFX knockout in mice have human homologs that are 385 specifically and significantly over-represented in Blue (p=0.0005) and Green 386 and paternally inherited genes beyond the previously described mechanisms of 427 parental imprinting and genomic conflict-with consequences for our mechanistic 428 understanding of sex-biased evolution and disease 19 . 429
Beyond their theoretical implications, our data help to pinpoint specific 430 genes that are likely to play key roles in mediating sex chromosome dosage 431 effects on wider genome function. Specifically, we establish that a distinctive 432 group of sex-linked genes -notable for their evolutionary preservation as X-Y 433 gametolog pairs across multiple species, and the breadth of their tissue 434 expression in humans 10 -are further distinguished from other sex-linked genes 435 by their exquisite sensitivity to SCD, and exceptionally close co-expression with 436 SCD-sensitive autosomal genes. These results add critical evidence in support of 437 the idea that X-Y gametologs play a key role in mediating SCD effects on wider 438 genome function. In convergent support of this idea we show that (i) multiple 439 SCD-sensitive modules of co-expressed autosomal genes are enriched with 440 TFBS for an X-linked TF from the highly dosage sensitive ZFX-ZFY gemetolog 441 pair, and (ii) ZFX deletion causes targeted gene expression changes in such 442
modules. 443
Gene co-expression analysis also reveal the diverse domains of cellular 444 function that are sensitive to SCD -spanning cell cycle regulation, protein 445 trafficking and energy metabolism. These effects appear to be specific to shifts in 446 SCD as they are not induced by trisomy of chromosome 21. Furthermore, gene 447 co-expression analysis of SCD effects dissects out specific immune activation 448 pathways that are upregulated by supernumerary X-chromosomes in males, and 449 enriched for genes known to confer risk for autoimmune disorders that 450
overrepresented amongst males bearing an extra X-chromosome. Thus, we 451 report coordinated genomic response to SCD that could potentially explain 452 observed patterns of disease risk in SCA. Collectively, these novel insights serve 453 to refine current models of sex-chromosome biology, and advance our 454 understanding of genomic pathways through which sex chromosomes can shape 455 phenotypic variation in health, and sex chromosome aneuploidy. participants in the microarray study, who each also provided a separate LCL 473 sample for the qPCR study ( Table 1) . 474 475 476 Microarray data preparation, differential expression analysis, annotation 477 and probe selection 478
Gene expression was profiled using the Illumina HT-12 v4 Expression 479
BeadChip Kit (Illumina Inc, San Diego, CA). Expression data were quantile 480 normalized across arrays and log2 transformed using the limma package in R 21 . 481
For each of 47323 probes, we estimated mean expression by karyotype group, 482 and log2 fold change in gene expression for each unique pairwise group contrast 483 between karyotype groups (Fig. 1a) , along with their associated false-discover-484 rate (FDR) corrected p-values. For each pairwise karyotype group comparison, 485 we identified probes with significant log2 fold-changes that survived FDR 486 correction for multiple comparisons across all 47323 probes with q (the expected 487 proportion of falsely rejected nulls) set at 0.05. We also calculated a single 488 summary estimate of SCD effects for each probe, by calculating the proportion of 489 variance (r 2 ) in probe expression that was accounted for by the 7-level factor of 490 SCD group. 491
All 47323 microarray probes were annotated using both the vendor 492 manifest file and an independently published re-annotation that assigns a quality 493 rating to each probe based on the specificity of its alignment to the purported 494 transcript target 22 . We filtered for all probes with "perfect" or "good" quality 495 alignment to a known gene according to this reannotation, and then used the 496 collapseRows function from the WGCNA 23 package in R (with default settings), to 497 select one probe per gene. These steps resulted in high-quality measures of 498 expression and estimates of differential expression for 19984 autosomal and 894 499 sex-chromosome genes in each of 68 independent samples from 7 different 500 karyotype groups. 501
To select a log2 threshold for use in categorical definition of differentially 502 expressed genes (DEGs), we estimated DEG count across a range of absolute 503 log2 fold-change cut-offs for 6 contrast of primary interest: karyotypically normal 504 males vs. females (i.e. XY vs. XX), and each SCA group vs. its respective 505 "gonadal control" (i.e XX was the control for XO and XXX groups / XY was the 506 control for XXY, XYY and XXYY). An absolute log2 fold change of 0.26 507 (equivalent to a ~20% increase/decrease in expression) was empirically selected 508 as the cut-off to define differential expression by (i) separately identifying the 509 increase in log2FC threshold that cause the greatest drop in DEG count for each 510 SCA group, (ii) averaging these log2FC thresholds across all 5 SCA groups. 511 512
Identifying Genes Showing Significant Differential Expression Across All 513

Sampled Changes in X-and Y-Chromosome Count 514
The 21 unique pairwise karyotype group comparisons in our microarray 515 dataset included 15 contrasts involving a disparity in X-chromosome count, and 516 16 contrasts involving a disparity in Y-chromosome count (Fig. 1a) . Using the 517 empirically-defined |log2 fold change| cut-off of 0.26 (see above), we screened all 518 20878 genes for evidence of significant differential expression across all 519 instances of X-or Y-chromosome disparity. 520 521
Comparing SCD Sensitivity of Gametolog vs. non-Gametolog Sex-Linked 522
Genes 523
Fourteen of 16 established 9 X-Y gametolog gene pairs were represented 524 in our microarray dataset. To compare the SCD sensitivity of this gene set to that 525 of non-gametolog sex-linked genes by we first quantified the mean effect of SCD 526 group on gene expression within the gametolog gene by averaging gene-wise r-527 squared values for the effect of SCD group on expression. We then determined 528 the centile of this observed gene set mean r-squared against a distribution of r-529 squared values for 10,000 similarly sized sets of randomly samples non-530 gametolog sex-linked genes (Fig. 1d) . This procedure was conducted separately 531 for X-and Y-chromosomes. 532
533
A Priori Assignment of Sex Chromosome Genes to Four Class Model 534
Categories 535 PAR genes were defined as those lying distal to the PAR1 and PAR2 536 boundaries specified in hg18 build of the human genome. Y-linked and X-linked 537 genes were defined as those lying proximal to these PAR boundaries on the Y-538 and X-chromosome respectively. X-linked genes were assigned to XCIE and XCI 539 using consensus classifications from a systematic integration 8 of XCI calls from 3 540 large-scale assays: expression from the inactivated human X-chromosome in 9 541 hybrid human-mouse cell lines 24 , allelic-imbalance analysis of expression data in 542 cell-lines from females with skewed X-inactivation 25 , and X-chromosome 543 methylation data from microarray 26 . According to the XCI categories of this 544 29 consensus report we classified X-linked genes as X-inactivated ("Subject" or 545 "Mostly Subject" categories), X-escape ("Escape" or "Mostly Escape" categories), 546 of-squared residuals against k indicated an optimal 6-cluster solution 555
( Supplementary Fig. 2a ). The largest of these 6 clusters (Gray cluster) gathered 556 genes with low or undetectable expression levels across all samples, and was 557 excluded from further analysis. 558
Reproducibility of 6 cluster solution was established using a bootstrap 559 method whereby individuals were randomly drawn (with replacement) from each 560 SCD group within our microarray dataset to derive 1000 bootstrap sets of 68 561 samples. k-means clustering was repeated for each of these 1000 sets to define 562 a 6-cluster solution in each draw (Supplementary Fig. 2b) . Consistency of 563 clustering was quantified for each gene as the proportion of bootstrap draws in 564 which it was assigned to the same cluster as it had been in the original sample. 565
The median consistency score for cluster designation was >93% for all 5 clusters 566 of SCD-sensitive sex chromosome genes. 567
30
The observed grouping of sex chromosome genes from k-mean 568 clustering, was compared with the predicted Four Class Model groupings using 569 two-tailed Fishers tests for all potential cluster-grouping combinations (Fig. 2b) . 570 571
Modelling X-and Y-chromosome Dosage Effects on Expression of Sex 572
Chromosome Gene Clusters 573
We used the following linear models to estimate the combined influence of 574 X and Y chromosome dosage in cluster and gene-level expression of Yellow 575 (XCI enriched) and Green (XCIE enriched) gene clusters: 576
We computed p-values for comparisons of both b 1 and b 2 coefficient 578 estimates against the null (0), and used these to test for significant directional 579 effects of sex chromosome dosage on the mean expression of each gene 580 cluster, as well the expression of individual genes within each cluster. 581 582
Aligning Sex Chromosome Expression, Epigenetic and Evolutionary Data 583
We validated our data-driven clustering of X-linked genes into Yellow (XCI 584 enriched) and Green (XCIE enriched) groups, by overlapping the genomic 585 coordinates of gene probes with segmentations of the X-chromosome according 586 to (i) "chromatin states" defined by computational analysis of coordinated 587 changes in 10 distinct chromatin marks in LCLs 14 , (ii) "evolutionary strata" 588 reflecting staged loss of recombination between the X-and Y-chromosome 13 . 589
Overlaps of our probe coordinate with these two annotations were defined using 590 the GenomicRanges package in R. As a third validation we also aligned our 591 clustering of X-lined genes with a previously published annotation of X-linked 592 genes according to whether their corresponding ancestral Y-linked homologue 593 has been lost, converted to a pseudogene or maintained 8 . Non-random 594 associations between these three annotations and Yellow vs. Green k-means 595 cluster membership were assessed using Chi-squared tests. 596 597
Comparison of DEG Count and Genomic Distribution Across SCA Groups 598
Total DEG counts were compared across SCD groups across a range of 599 log 2 fold change cut-offs as described above and reported in Fig 3 a.b . To test 600
for non-random distribution of DEGs across the genome in each SCD group (Fig.  601   3c) , we compared observed DEG counts across 4 genomic regions -autosomal, 602 PAR, Y-linked and X-linked -to the background distribution of total gene counts 603 across these regions using the prop.test function in R. All SCD groups showed a 604 high non-random distribution of DEGs across the genome -reflecting preferential 605 involvement of sex chromosome genes (p < 7.2 * 10 -13 ). 606 607
Quantitative rtPCR validation of Differentially-Expressed Genes in 608
Microarray 609
Selecting genes of interest: For selected genes showing significant differential 610 expression between karyotype groups in our core sample, we used qPCR to 611 validate and extent observed fold-changes in an independent sample of 401 612 participants representing all the karyotypes in our core sample plus two 613 using Chi-squared tests ( Table 4) . To test if T21 showed a similar shift in gene 773 co-expression modules to sex chromosome trisomies, we used the designation 774 of genes to modules in the SCA sample to recalculate module Eigengenes. We 775 then calculated MR fold changes for T21 and three SCA trisomies (XXX, XXY 776 and XYY). Trisomy of chromosome 21 was associated with a clearly distinct 777 profile of ME expression chance than all three of the SCA trisomies (Fig. 4c) . 778 (Tables provided as individual . xlsx files due to size) the Yellow cluster enriched for XCI genes is less expressed in groups with greater Xchromosome count, and (ii) Yellow and Green clusters enriched for XCI and XCIE genes respectively are both differentially expressed between groups that differ in Y-chromosome status, but have identical X-chromosome count.
TABLE LEGENDS
Table 3. Characteristics of Gene-Coexpression Modules Generated by WGCNA. For all 19
modules defined by WGCNA, we provide information regarding: module size; "top" module genes [defined by strength of correlated expression with module eigengene (ME) ]; proportion variance in module expression explained by ME; ME correlation with other ME of all other modules; F-test for effect of SCD on ME variance; results of t-tests for selected group differences in ME expression (bold cells survive Bonferroni correction for # modules); significant GO term enrichment by GOelite and GOrilla; binary statement regarding whether module shows both significant SCD sensitivity and significant GO terms enrichment Table 4 . Cross-tabulations and associated Chi-squared tests for overlap in differentially expressed genes between trisomy 21 and the 3 sex-chromosome trisomies in our sample.
Note, these calculations were made after removal of genes located on sex chromosomes, or chromosome 21. For this comparison, differential expression was defined as a statistically significant fold change in expression of any magnitude that survived FDR correction for multiple comparisons at q=0.05 This liberal fold-change cut-off was applied given the to accommodate the very small number of DEGs seen in XXX
